2Norata GD, Marchesi P, Passamonti S, et al. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice[J]. Atherosclerosis, 2007, 191(2): 265-271.
3Michael A, Bianca F. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis[ J]. Atherosclerosis, 1998, 137(1): 45 - 50.
4Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation [J]. Free Radical Biol Med, 1997, 23(2) : 302- 313.
5Fuhnnan B, Volkova N, Dornfeld L, et al. Pomegranate juice consumption reduces oxidative stress and low density lipoprotein atherogenic modifications: studies in the atherosclemtic apolipoprotein E deficient mice and in humans[J].Atherosclerosis, 2000, 151(1): 111-119.
6Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture [ J ]. Curr Vasc Pharmacol, 2005. 3(1): 63-68.
7Ma Q, Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages [ J ]. J Biol Chem, 2002, 277 (4): 2 477 - 2 484.
8Fuhrman B, Volkova N, Coleman R, et al. Grape powder polyphenols attenuate atherosclerosis development in apolipoprolein E deficient (E0) mice and reduce macrophage atherogenicity[J]. J Nutr, 2005, 135(4): 722-728.
9Stamler J, Wentworth D, Neaton JD, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) [ J]. JAMA, 1986, 256 (20): 2 823 - 2 828.
10Schoenhagen P, Tuzcu EM, Elilis SG. PPlaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process [J]. Circulation, 2002, 106 (7) : 760- 762.
